Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David G Lalloo

Showing results (11-20 of 216) with videos related to

Pageof 22
Sort By:
Current Opinion in Infectious Diseases|July 10, 2009
Treatment of cryptococcal meningitis in resource limited settingsDerek J Sloan, Martin J Dedicoat, David G Lalloo
Nature|November 3, 2006
No room for complacency on drug resistance in AfricaIan M Hastings, David G Lalloo, Saye H Khoo
AIDS (London, England)|January 2, 2007
Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'Ian M Hastings, David G Lalloo, Saye H Khoo
The Cochrane Database of Systematic Reviews|June 15, 2012
Artesunate versus quinine for treating severe malariaDavid Sinclair, Sarah Donegan, Rachel Isba, et al.
Tropical Medicine & International Health : TM & IH|October 20, 2010
Challenges in HIV and visceral leishmania co-infection: future research directionsZewdu Hurissa, Luis E Cuevas, David G Lalloo, et al.
Lancet (London, England)|May 4, 2002
The African challengeDavid G Lalloo, R David G Theakston, David A Warrell
BMJ (Clinical Research Ed.)|May 23, 2013
Investigation and treatment of imported malaria in non-endemic countriesChristopher J M Whitty, Peter L Chiodini, David G Lalloo
Vaccine|May 15, 2016
Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidenceM Gabriela M Gomes, Stephen B Gordon, David G Lalloo
The New England Journal of Medicine|June 28, 2013
Combination antifungal therapy for cryptococcal meningitisJeremy N Day, Tran T H Chau, David G Lalloo
Journal of Infection and Public Health|August 13, 2010
Epidemiology and outcome of snake bite cases evaluated at a Tertiary Care Hospital in OmanAdil Al-Lawati, Seif S Al-Abri, David G Lalloo
Pageof 22

Showing results (11-20 of 216) with videos related to

Sort By:
Pageof 22
Current Opinion in Infectious Diseases|July 10, 2009
Treatment of cryptococcal meningitis in resource limited settingsDerek J Sloan, Martin J Dedicoat, David G Lalloo
Nature|November 3, 2006
No room for complacency on drug resistance in AfricaIan M Hastings, David G Lalloo, Saye H Khoo
AIDS (London, England)|January 2, 2007
Continued correspondence 'Will ART rollout in Africa drive an epidemic of drug-resistant HIV?'Ian M Hastings, David G Lalloo, Saye H Khoo
The Cochrane Database of Systematic Reviews|June 15, 2012
Artesunate versus quinine for treating severe malariaDavid Sinclair, Sarah Donegan, Rachel Isba, et al.
Tropical Medicine & International Health : TM & IH|October 20, 2010
Challenges in HIV and visceral leishmania co-infection: future research directionsZewdu Hurissa, Luis E Cuevas, David G Lalloo, et al.
Lancet (London, England)|May 4, 2002
The African challengeDavid G Lalloo, R David G Theakston, David A Warrell
BMJ (Clinical Research Ed.)|May 23, 2013
Investigation and treatment of imported malaria in non-endemic countriesChristopher J M Whitty, Peter L Chiodini, David G Lalloo
Vaccine|May 15, 2016
Clinical trials: The mathematics of falling vaccine efficacy with rising disease incidenceM Gabriela M Gomes, Stephen B Gordon, David G Lalloo
The New England Journal of Medicine|June 28, 2013
Combination antifungal therapy for cryptococcal meningitisJeremy N Day, Tran T H Chau, David G Lalloo
Journal of Infection and Public Health|August 13, 2010
Epidemiology and outcome of snake bite cases evaluated at a Tertiary Care Hospital in OmanAdil Al-Lawati, Seif S Al-Abri, David G Lalloo
Pageof 22